Newsroom
Verantos and Amgen publish on AI in asthma
Given that each patient’s asthma journey and disease severity are influenced by a complex constellation of factors, AI-based approaches are ideally suited to identify asthma outcomes when the proper inputs are provided and especially when the real-world data used to develop these models are enhanced with unstructured electronic health record data. This manuscript summarizes efforts to use AI to predict exacerbations, ED visits, and admissions — all clinically relevant endpoints in asthma real-world evidence.
Read at the original outletAll news